English
|
Français
Font Size:
A
A
A
Donate
About
Mission and Values
Type 1 Diabetes
Your Money at Work
What Does JDRF Stand For?
Our Board of Directors
Our Executive Team
Annual Reports
Careers
Our Research
Research
Cure
Immune Therapies Research
Regeneration Research
Replacement Research
Prevent
Prevention Research
Treat
Artificial Pancreas Project
Glucose Control Therapy Research
Complications Prevention Research
Meet Our Researchers
JDRF CCTN
Type 1 Diabetes TrialNet
Funding Opportunities
T1Digest
Clinical Trials
About JDRF Clinical Trials
Our Mission
Funders and Donors
How to Support JDRF CCTN
JDRF CCTN Clinical Trials
Get Involved
JDRF House ParT1D for a Cure
Sun Life Ride to Defeat Diabetes for JDRF
JDRF's Monthly giving program: In to End Diabetes
Volunteer
Fundraise Your Way
Holiday Mystery Box
Winnipeg Gala
BC Gala
Planned Giving
Why JDRF
Charitable Bequest
RRSP/RRIF Funds
Gifts of Securities & Flow-Thru Shares
Life Insurance
Charitable Gift Annuity
Charitable Remainder Trust
The BETA Society
Legacy Challenge
Request for More Information
Join Us
Resources
Blog
Bag of Hope
Let's Talk T1D
Talk T1D Peer Support
Toddler and school age
Adults
Advocacy
Advocacy
Kids for a Cure Lobby Day 2020
Meet our Delegates
Access For All
Write your representative
Vote Type None
Take Action: Help Remove Age Restrictions on Insulin Pump Coverage
Take Action: Support T1D Students
Advocate Resources
Advocate Feedback
JDRF Position Statement on Diabetes Management in Schools
Diabetes Research Symposium
Our Supporters
Corporate Initiatives
Our Corporate Heroes
Locations
Locations Map
Atlantic
New Brunswick
Nova Scotia
BC & Yukon
Vancouver
Interior BC
Vancouver Island, Northern BC and Yukon
Alberta & North West Territories
Northern Alberta (including Edmonton)
Southern Alberta
Ontario
Hamilton
Windsor
Barrie
London
Waterloo
Peel/Halton Region
Thunder Bay (managed by Winnipeg)
Toronto
Ottawa
Manitoba
Winnipeg (incl. Thunder Bay)
Saskatchewan
Regina
Quebec
Montreal
Quebec City
News & Media
Press Room
Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes
JDRF Canada is marking National Diabetes Awareness Month by asking those impacted to write a letter to type 1 diabetes with the launch of their "Dear Type 1" Campaign
JDRF and Sun Life challenge corporate Canada to move work aside and move for a cure
Your Dollars at Work: How your support is changing the landscape of T1D research
The JDRF House ParT1D for a Cure presented by Omnipod raises $2.1 million dollars to accelerate research
The JDRF House ParT1D for a Cure presented by Omnipod New virtual fundraiser unveiled in support of type 1 diabetes research
JDRF welcomes announcement from the Government of Canada to better support Canadians with disabilities during COVID-19, including those living with type 1 diabetes
New UK studies examine risks of COVID-19 in people with type 1 diabetes
JDRF and Lilly advance stem cell-based therapy research in Canada with new fellowship
The JDRF - Beyond Type 1 Alliance Releases Recommendations for People with Diabetes During COVID-19 Pandemic
JDRF Calgary cancels in-person "Picks and Plates" Gala Organization taking steps in response to Coronavirus Outbreak
Finance Committee's Budget Recommendations Positive for Canadians with Diabetes
JDRF Canada responds to INESS recommendations regarding Dexcom G6 Continuous Glucose Monitor
Max Domi launches fund to help Canadians living with type 1 diabetes
JDRF welcomes effort to expand Disability Tax Credit eligibility for Canadians with diabetes
Interview opportunity: JDRF celebrates the announcement of Dexcom G6 CGM System's availability in Canada
JDRF and Boston Pizza empower the T1D community with $105,000 in education grants
Statement by Dave Prowten, President and CEO JDRF Canada
B.C. native, Samir Dattani, represents Canada at JDRFI's Children's Congress in Washington, D.C.
NHL player Max Domi laces up to lead the Sun Life Walk to Cure Diabetes for JDRF in Montreal
JDRF welcomes Disability Advisory Committee's recommendation that all Canadians needing life-sustaining therapy should automatically meet the criteria for the Disability Tax Credit and urges the Government to adopt this approach
Montreal Canadiens star and JDRF National Spokesperson Max Domi joins Montreal-area kids living with type 1 diabetes May 28 for a frank discussion on the disease
JDRF Expresses Profound Loss at the Passing of Helaine Shiff, co-founder of JDRF Canada
Boston Pizza is advancing the academic goals of young people through two new initiatives in support of JDRF
JDRF International Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO
Sun Life deepens commitment to fight type 1 diabetes in Canada with title sponsorship of JDRF signature fundraising event, the Sun Life Ride to Defeat Diabetes for JDRF
JDRF Canada is extremely pleased with the House of Commons Standing Committee on Health Report on a Diabetes Strategy for Canada
JDRF announces new Chief Scientific Officer, Dr. Sarah Linklater
JDRF welcomes Government's decision to end RDSP clawbacks when DTC status lost, but says opportunity missed to support Canadians with diabetes through a national diabetes strategy
Lilly Canada and JDRF Canada Award Post-doctoral Fellowships in Type 1 Diabetes Research
JDRF Canada and Diabetes Canada light the province of BC blue on World Diabetes Day Nov. 14th to raise awareness
JDRF's promise to the T1D Community
JDRF celebrates Health Canada's new licence for technology that will improve the lives of people with type 1 diabetes
JDRF Canada welcomes Senate report on "Breaking Down Barriers" for Canadians with Disabilities in accessing the Disability Tax Credit and Registered Disability Savings Plan
JDRF Canada applauds BC government's decision to provide insulin pumps to people of all ages who live with type 1 diabetes
Sun Life Financial grows efforts to fight type 1 diabetes in Canada with title sponsorship of the JDRF Walk to Cure Diabetes
Government of Canada and JDRF invest $7.7M in type 1 diabetes care and treatments
JDRF Canada Proudly Announces Max Domi and Bell Media Partnerships
JDRF welcomes CRA review of diabetes denials
Internal CRA documents show intent to deny the disability tax credit to Canadians with type 1 diabetes
JDRF's T1D heroes advocating for insulin pump coverage in Manitoba
Ford Motor Company Windsor reaches $1M fundraising milestone for diabetes research
JDRF and Diabetes Canada join together to propose a solution for Canadians with diabetes on the Disability Tax Credit
Letter from JDRF and Diabetes Canada to the Honourable Diane Lebouthillier regarding joint recommendations aimed at ensuring access to the Disability Tax Credit for Canadians with diabetes
JDRF-Funded Study on Continuous Glucose Monitoring (CGM) in Pregnant Women with Type 1 Diabetes Shows Improved Outcomes for Their Newborns
JDRF advocates for all Canadians living with type 1 diabetes to be eligible for the Disability Tax Credit
JDRF and Sun Life Financial team up to raise funds for diabetes research
Lilly Canada and JDRF Canada Award Post-doctoral Fellowships in Type 1 Diabetes Research
UBC researchers working to engineer 'tunable' insulin production
Cultivating a cure for type 1 diabetes
Marley Greenberg represents Canada at JDRFI Children's Congress in Washington, D.C.
Thousands of Canadians walk with JDRF to find a cure for type 1 diabetes
JDRF and Lilly Canada requesting applications from postdoctoral fellows engaged in clinical type 1 diabetes research
Northland Properties president, Tom Gaglardi, announces $3 million gift to JDRF Canada
Government of Canada and JDRF join forces to defeat diabetes
JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin
The 2016 JDRF DIA-BEAT-IT Gala exceeds its goal!
JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
JDRF funds U of T Engineering research to improve cell transplantation to treat type 1 diabetes
JDRF and McGill University work to optimize performance of artificial pancreas systems
JDRF and the University of Alberta work to one day make insulin injections a thing of the past
JDRF and UHN's McEwen Centre for Regenerative Medicine use stem cells and a new implantable device to take us one step closer to finding a cure for type 1 diabetes
JDRF and UBC work to eliminate the burden for those living with type 1 diabetes
Major investment in T1D research
Defymed Receives Support from JDRF to Fight Type 1 Diabetes
Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes
JDRF Honors Type 1 Diabetes Research Champions
JDRF and Sun Life Financial team up in the Revolution to Defeat Diabetes
JDRF CELEBRATES WORLD HEALTH DAY ADVOCATING FOR COMMUNITY ENGAGEMENT AND THE ACCELERATION OF TYPE 1 DIABETES RESEARCH
JDRF APPLAUDS WORLD HEALTH DAY ADVOCATING TO END DIABETES
Exciting finding announced by JDRF-funded researcher
JDRF-funded research points the way towards novel treatment for type 1 diabetes
JDRF and Sanofi Announce Expansion of their Joint Research Collaboration to Include Development of Glucose Responsive Insulin Therapies for Treatment of Insulin-Dependent Diabetes
Researchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months
Alberta Site Currently Recruiting for ViaCyte Inc. Clinical Trial
Lilly Canada and JDRF Canada Award Post-doctoral Fellowships in Type 1 Diabetes Research
JDRF in the Globe and Mail, November 30, 2015
Releasing Insulin Like Clockwork
Collaboration Leads to Invaluable Discoveries
JDRF in the Globe and Mail, November 12, 2015
New Classification and Staging Approach for Presymptomatic Type 1
Corporate Canada Mounts Up at the Annual JDRF Ride for Diabetes Research
The U.S. National Institutes of Health support diabetes research at the IRCM
ViaCyte Announces Highly Anticipated Encapsulation Clinical Trial Site Expansion into Canada
MUHC conducts first islet cell transplant in Quebec
Two-year $300 Million Extension of the Special Diabetes Program Allows for the Continuation of Promising Ongoing Clinical Trials
JDRF-Supported Researchers Make Gains in Designing Islet Cell Encapsulation Materials for Use in Type 1 Diabetes Therapies
BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart Technology Designed to Improve Insulin Pump Therapy
BD Receives FDA Clearance for a Novel Infusion Set with BD FlowSmart Technology to Enhance the Use of Insulin Pumps
14-Year-Old from Vancouver to Represent Canada at JDRF 2015 Children's Congress
REGiMMUNE Announces Collaboration with JDRF and Pfizer Inc. for Type 1 Diabetes Prevention and Treatment Promoting Regulatory T-Cells
JDRF in the Globe and Mail, April 1, 2015: Improving the chances for healthy pregnancies.
ViaCyte Receives Clearance from Health Canada for Diabetes Clinical Trial
JDRF Announces New Partnership with the European Foundation for the Study of Diabetes and Eli Lilly and Company to Fund Novel Diabetes Research
Stem cells show promise for reversing Type 2 diabetes
Major Milestone in Communications Standards for Diabetes Devices
JDRF in the Globe and Mail, November 25, 2014: For kids, research and new treatment options bring less discomfort and better outcomes
JDRF-Funded Islet Encapsulation Program Reaches Historic Milestone
JDRF On Canada AM
Type 1 Diabetes: What You Need To Know Now
Media Contacts
Donate
General Donation
Monthly Giving
Beyond Insulin
Matching Gifts Program
In Honour Donation
In Memory Donation
Pledge a Ride Participant
Pledge a Walk Participant
Securities Donation
Donate your Vehicle
JDRF-Home
JDRF Blog
Halloween 2020 Guide
Halloween 2020 Guide
October 28, 2020
Menu
More
_Page_1.png)
_Page_2.png)
